Ph.D., DVM, MBA
Chief Drug Discovery Officer
Uri Herzberg has extensive expertise in drug discovery with companies including Johnson & Johnson, Celgene, Cabaletta Bio, Celularity and Fresh Tracks Therapeutics. His expertise encompasses preclinical development, translational research, regulatory strategy, early clinical trial design target identification and indication selection. He holds a doctorate in veterinary medicine, a Ph.D. in veterinary biology and neuroimmunology and an MBA in pharmaceutical development.